denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: Alexion and Novartis
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Treatment Considerations
Hematology Disease Topics & Pathways:
Treatment Considerations
Friday, December 6, 2024: 11:00 AM-2:00 PM
Marriott Grand Ballroom 5-6
(Marriott Marquis San Diego Marina)
Speakers:
Srikanth Nagalla, Baptist Health South Florida
and
Christopher Patriquin, MD, MSc, FRCPC, Division of Medical Oncology & Hematology, University Health Network
Disclosures:
Nagalla: Alexion, Sanofi, Agios, Apellis, Rigel, Sobi, Pharmacosmos: Consultancy; Alexion, Sanofi, Agios, Apellis, Rigel, Sobi: Speakers Bureau. Patriquin: Sanofi: Consultancy, Honoraria; Takeda: Consultancy, Honoraria; Sobi: Consultancy, Honoraria; BioCryst: Consultancy, Honoraria; Roche: Consultancy, Honoraria; Alexion, AstraZeneca Rare Disease: Consultancy, Honoraria, Other: Served as a clinical site investigator ; Apellis: Consultancy, Honoraria, Other: Served as a clinical site investigator ; Novartis: Consultancy, Honoraria; Amgen: Consultancy, Honoraria.
On Demand program will be available here December 21, 2024.
This interactive, live symposium will focus on all aspects of PNH through the lens of the patient journey. Expert faculty will review the complement pathway, highlight diagnostic challenges, and discuss current and emerging treatment options, while listening to a patient share their experiences. A collaborative approach to patient care will be a key focus of the presentation as faculty prioritize care and quality of life for patients with PNH.
See more of: Friday Satellite Symposia